Aquamin for Knee Osteoarthritis
Author Information
Author(s): Joy L Frestedt, Michael A Kuskowski, John L Zenk
Primary Institution: Frestedt Incorporated
Hypothesis
Can a natural seaweed-derived mineral supplement (Aquamin) improve symptoms in patients with knee osteoarthritis?
Conclusion
Aquamin may help increase range of motion and walking distances in knee osteoarthritis patients while allowing for reduced NSAID use.
Supporting Evidence
- Aquamin group showed significant improvements in range of motion and walking distance compared to placebo.
- The study included 29 subjects, with 22 proceeding to treatment.
- 14 subjects completed the study, indicating a high dropout rate.
Takeaway
This study looked at a seaweed supplement to see if it could help people with knee pain walk better and move more easily.
Methodology
A double-blind, placebo-controlled pilot study with 29 subjects randomized to receive either Aquamin or placebo for up to 12 weeks.
Potential Biases
Potential bias due to the small number of subjects and the nature of self-reported outcomes.
Limitations
The study had a small sample size and short duration of treatment.
Participant Demographics
Subjects were aged 35-75, with a mix of genders, diagnosed with moderate to severe knee osteoarthritis.
Statistical Information
P-Value
0.028
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website